Research in the MUSC Division of Pulmonary, Critical Care and Sleep Medicine covers the spectrum of basic mechanisms of disease, translational research, clinical trials, and outcomes research. Areas of particular emphasis include interstitial lung diseases, including idiopathic pulmonary fibrosis, critical illness, lung cancer, cystic fibrosis, and rare lung diseases.
Our research program also leverages the numerous resources available within MUSC, including the South Carolina Clinical & Translational Research Institute (NIH Clinical Translational Science Award), MUSC Center for Health Disparities Research, and the Charleston VA HSR&D Centers of Innovation (COIN). MUSC was awarded a SC Center of Economic Excellence in Inflammation and Fibrosis with goal of developing new therapies for inflammatory and fibrosing conditions. To accelerate research, a $10 million renovation of the 9th floor Clinical Sciences Building was completed in 2015. The new laboratory space now houses a multidisciplinary group of researchers focusing on inflammation and fibrosis that will maximize shared equipment and facilitate collaborative research.